English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1503214      線上人數 : 196
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    瀏覽

    子類別

    博碩士論文 [47/47]
    專利 [0/1]
    專書 [0/2]
    會議論文 [39/70]
    期刊論文 [234/284]
    研究計畫 [99/152]

    RSS Feed RSS Feed

    跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
    請輸入前幾個字:   

    顯示項目126-150 / 556. (共23頁)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

    日期題名作者
    2014-05-27 ERK-mediated HER2 Thr701 phosphorylation negatively regulates HER2/AKT axis activation through reducing EGFR/HER2 dimerization in a clathrin-dependent manner 魏雅鈴(Ya-Ling Wei); 陳雯淑(Chen Wen-Shu); 葉名焮(Ming-Hsin, Alex, Yeh); 陳韻如(Chen Yun-Ju); 黃偉謙(Wei-Chien Huang)*
    2015-11 Erythropoietin Stimulates Tumor Growth via EphB4 (326. Pradeep, S.); (Huang, J.); (Mora, E. M.); (Nick, A. M.); (Cho, M. S.); (Wu, S. Y.); (Noh, K.); (Pecot, C. V.); (Rupaimoole, R.); (Stein, M. A.); (Brock, S.); (Wen, Y.); (Xiong, C.); (Gharpure, K.); (Hansen, J. M.); (Nagaraja, A. S.); (Previs, R. A.); (Vivas-Mejia, P.); (Han, H. D.); (Hu, W.); (Mangala, L. S.); (Zand, B.); (Stagg, L. J.); (Ladbury, J. E.); (Ozpolat, B.); (Alpay, S. N.); (Nishimura, M.); (Stone, R. L.); (Matsuo, K.); (Armaiz-Pena, G. N.); (Dalton, H. J.); (Danes, C.); (Goodman, B.); (Rodriguez-Aguayo, C.); (Kruger, C.); (Schneider, A.); (Haghpeykar, S.); (Jaladurgam, P.); 洪明奇(Mien-Chie Hung); (Coleman, R. L.); (Liu, J.); (Li, C.); (Urbauer, D.); (Lopez-Berestein, G.); (Jackson, D. B.); (Sood, A. K.)*
    2001-10 Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes 宋賢穎(Shian-Ying Sung)*; (McDowell, J. V.); (Marconi, R. T.)*
    2002-08 Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes (McDowell, JV); 宋賢穎(Shian-Ying Sung); (Hu, LT); (Macroni, RT)
    2013-05 Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis 黃偉謙(Wei-Chien Huang)*; (Sheng-Chie Hsu); (Shyh-Jer Huang); (Yun-Ju Chen); (Yu-Chun Hsiao); (Weihua Zhang); (Isaiah J Fidler); 洪明奇(Mien-Chie Hung)*
    2009 Expanding the arsenal: metformin for the treatment of triple-negative breast cancer (Jiralerspong, S.); (Gonzalez Angulo, AM); 洪明奇(Mien-Chie Hung)*
    2012 Expression of Protein Kinase C α and the MZF-1 and Elk-1 Transcription Factors in Human Bladder Transitional Cell Carcinoma Cells 周詠欽(Yeong-Chin Jou); (Yung-Wei Chiu); (Yieng-How Chen); (Jin-Ming Hwang); (Pei-Yu Chao); (Jiuan-Jen Shiu); (Wen-Hung Hwang); 劉哲育(Liu Jer-Yuh)*; 許立松(Li-Sung Hsu)*
    2012 The Expression of Protein Kinase C α and the MZF-1 and Elk-1 Transcription Factors in Human Breast Cancer Cells 于家珩(Chia-Herng Yue); (Yung-Wei Chiu); (Jai-Nien Tung); (Bor-Show Tzang); (Jiuan-Jen Shiu); (Wen-Hung Huang); 劉哲育(Liu Jer-Yuh)*; 黃俊銘(Jin-Ming Hwang)*
    2000-06 Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue. (Mei-Ying Liu); (Ya-Yi Shih); 李龍緣(Long-Yuan Li); (Sheng-Ping Chou); (Tzung-Shiahn Sheen); (Chi-Long Chen); (Czau-Siung Yang); (Jen-Yang Chen)*
    2010 The expression patterns of ER, PR, HER2, CK5/6, EGFR. Ki-67 and AR by immuohistochemical analysis in breast cancer cell lines. (Subik K); (Lee, JF); (Baxter L,); (Strzepek T); (Costello D,); (Crowley P); 洪明奇(Mien-Chie Hung); (Bonfiglio T); (Hicks DG); (Tang P)*
    2010-02 Extended O6-Methylguanine Methyltransferase Promoter Hypermethylation Following n-Butylidenephthalide Combined with 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) on Inhibition of Human Hepatocellular Carcinoma Cell Growth 余永倫(Yung-Luen Yu); (SUNG-LIANG YU); (KUO-JUNG SU,); (CHYOU-WEI W); (MIN-HUI JIAN); 林珀丞(Po-Cheng Lin); (I-HSUAN TSENG); (CHAI-CHING LIN); 蘇進成(Chin-Cheng Su); (DE-CHUAN CHAN); 林欣榮(Shinn-Zong Lin); 韓鴻志(Horng-Jyh Harn)*; (YI-LIN CHEN)*
    2014-07 EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer (Debeb, B. G.); (Gong, Y.); (Atkinson, R. L.); (Sneige, N.); (Huo, L.); (Gonzalez-Angulo, A.); 洪明奇(Mien-Chie Hung); (Valero, V.); (Ueno, N. T.); (Woodward, W.)*
    2011-03 EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling 余永倫(Yung-Luen Yu)*; 鄒瑞煌(Ruey-Hwang Chou); (Ling-Tzu Chen); 徐偉成(Woei-Cherng Shyu); (Su-Ching Hsieh); (Chen-Shiou Wu); (Hong-Jie Zeng); 葉士芃(Su-Peng Yeh); (De-Ming Yang); (Shih-Chieh Hung); 洪明奇(Mien-Chie Hung)*
    2011-03 EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling 余永倫(Yung-Luen Yu)*; 鄒瑞煌(Ruey-Hwang Chou); (Ling-Tzu Chen); 徐偉成(Woei-Cherng Shyu); (Su-Ching Hsieh); (Chen-Shiou Wu); (Hong-Jie Zeng); 葉士芃(Su-Peng Yeh); (De-Ming Yang); (Shih-Chieh Hung); 洪明奇(Mien-Chie Hung)*
    2011-04-18 EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling 鄒瑞煌(Ruey-Hwang Chou); (Ling-Tzu Chen); 徐偉成(Woei-Cherng Shyu); (Su-Ching Hsieh); (Chen-Shiou Wu); (Hong-Jie Zeng); 葉士芃(Su-Peng Yeh); 余永倫(Yung-Luen Yu); 洪明奇(Mien-Chie Hung)*
    2017-08-22 EZH2 在惡性腦癌中扮演的角色 黃立佳; Li-Jia Huang
    2013-03-24 EZH2-mediated regulation of cancer cell migration. 黃耀群; 李龍緣(Long-Yuan Li); 李龍緣(Long-Yuan Li)
    2014-03 EZH2: novel therapeutic target for human cancer 李龍緣(Long-Yuan Li)*
    2012-10 EZH2:a pivotal regulator in controlling cell differentiation 陳雅惠(Ya-Huey Chen); 洪明奇(Mien-Chie Hung)*; 李龍緣(Long-Yuan Li)*
    2014-07-31 EZH2所調控的分子機制於骨癌發展過程及治療之研究 陳雅惠(Ya-Huey Chen); 李龍緣(Long-Yuan Li)
    2013-08 Fisetin Inhibits Migration and Invasion of Human Cervical Cancer Cells by Down-Regulating Urokinase Plasminogen Activator Expression through Suppressing the p38 MAPK-Dependent NF-κB Signaling Pathway. 鄒瑞煌(Ruey-Hwang Chou); (Hsieh SC); 余永倫(Yung-Luen Yu); (Huang MH); (Huang YC); (Hsieh YH)*
    2015-11 FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer (Han, B.); (Qu, Y.); (Jin, Y.); (Yu, Y.); (Deng, N.); (Wawrowsky, K.); (Zhang, X.); (Li, N.); (Bose, S.); (Wang, Q.); (Sakkiah, S.); (Abrol, R.); (Jensen, T. W.); (Berman, B. P.); (Tanaka, H.); (Johnson, J.); (Gao, B.); (Hao, J.); (Liu, Z.); (Buttyan, R.); (Ray, P. S.); 洪明奇(Mien-Chie Hung); (Giuliano, A. E.); (Cui, X.)*
    2009-03-21 FOXC2 Is Critical for Resveratrol-Mediated Inhibition of Metastasis in Lung Cancer 蘇振良(Jen-Liang Su)*
    2009-02-11 FOXC2 is Critical for Resveratrol-mediated Inhibition of Metastasis in Lung Cancer (yu-jhen cheng); 蘇振良(Jen-Liang Su)*; 蘇振良(Jen-Liang Su)
    2009-07-06 FOXC2於白藜蘆醇抑制肺癌細胞轉移之相關探討; FOXC2 is critical for resveratrol-mediated inhibition of metastasis in lung cancer 鄭羽真; Yu-Jhen Cheng

    顯示項目126-150 / 556. (共23頁)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋